(HOD) BetaPro Crude Oil Inverse - Ratings and Ratios

Exchange: TO • Country: Canada • Currency: CAD • Type: Etf • ISIN: CA08662J1003

Inverse, Leveraged, Derivatives, Futures, Swaps

Description: HOD BetaPro Crude Oil Inverse

The BetaPro Crude Oil Inverse Leveraged Daily Bear ETF (HOD) is a Canadian ETF that provides inverse leveraged exposure to the daily performance of crude oil. It is designed for investors seeking to profit from a decline in crude oil prices.

As an inverse leveraged ETF, HOD is likely to be highly volatile and may experience significant losses if crude oil prices rise. The funds investment strategy involves using derivatives to achieve its investment objective, which can result in amplified gains or losses. Investors should be aware that the funds performance can be highly sensitive to changes in crude oil prices and may not be suitable for all investors.

Analyzing the available , we can see that HODs price is currently at 6.75 CAD, below its 20-day SMA of 7.29 CAD, indicating a potential downtrend. The 50-day SMA is at 6.96 CAD, while the 200-day SMA is at 6.72 CAD, suggesting a possible bearish crossover. The ATR of 0.49 CAD, representing 7.23% of the current price, indicates high volatility. Given these technical indicators, a potential short-term target for HOD could be its 52-week low of 4.98 CAD.

Considering the , the AUM of 39.01M CAD suggests that HOD has a relatively small asset base, which may impact its liquidity. However, this also indicates that the fund is not overly large, and its investment strategy can be effectively implemented.

Based on the available data, a forecast for HOD can be made. If crude oil prices continue to decline, HOD is likely to experience a significant increase in value due to its inverse leveraged nature. However, if crude oil prices rise, HODs value will likely decline. Using the available technical and fundamental data, a potential trading strategy could involve monitoring crude oil prices and adjusting positions accordingly. A break below the 52-week low of 4.98 CAD could indicate a further decline, while a rise above the 20-day SMA of 7.29 CAD could signal a potential reversal. Investors should closely monitor market conditions and adjust their strategies accordingly.

Additional Sources for HOD ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

HOD ETF Overview

Market Cap in USD 29m
Category Passive Inverse/Leveraged
IPO / Inception 2008-01-15

HOD ETF Ratings

Growth Rating -77.8
Fundamental -
Dividend Rating 0.0
Rel. Strength -24.3
Analysts -
Fair Price Momentum 3.07 CAD
Fair Price DCF -

HOD Dividends

Currently no dividends paid

HOD Growth Ratios

Growth Correlation 3m -74.2%
Growth Correlation 12m -21.3%
Growth Correlation 5y -94%
CAGR 5y -49.68%
CAGR/Max DD 5y -0.51
Sharpe Ratio 12m 0.23
Alpha -2.57
Beta -1.181
Volatility 103.11%
Current Volume 1782k
Average Volume 20d 1785k
What is the price of HOD shares?
As of July 03, 2025, the stock is trading at CAD 5.32 with a total of 1,781,970 shares traded.
Over the past week, the price has changed by -6.67%, over one month by -20.00%, over three months by -6.67% and over the past year by -12.07%.
Is BetaPro Crude Oil Inverse a good stock to buy?
No, based on ValueRay´s Analyses, BetaPro Crude Oil Inverse (TO:HOD) is currently (July 2025) a stock to sell. It has a ValueRay Growth Rating of -77.81 and therefor a clear technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HOD is around 3.07 CAD . This means that HOD is currently overvalued and has a potential downside of -42.29%.
Is HOD a buy, sell or hold?
BetaPro Crude Oil Inverse has no consensus analysts rating.
What are the forecasts for HOD share price target?
According to our own proprietary Forecast Model, HOD BetaPro Crude Oil Inverse will be worth about 3.3 in July 2026. The stock is currently trading at 5.32. This means that the stock has a potential downside of -37.59%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 3.3 -37.6%